Overview

Split-face Study Comparing the Cosmetic Efficacy and Tolerability of Two Topical Products in Participants With Moderate Facial Melasma

Status:
Completed

Trial end date:
2017-10-09

Target enrollment:

Participant gender:

Summary

The objective of this study is to evaluate the efficacy and tolerability of Lytera 2.0 versus 4% hydroquinone in the improvement of the appearance of moderate facial melasma.

Phase:

N/A

Details

Lead Sponsor:

Allergan

Treatments:

Hydroquinone
Sunscreening Agents